Home
Archives
Contact
About
Biotechnology Books
Publishing Opportunities
Pharma Industry Reports
The business of biotechnology
Twitter
Linkedin
Rss
Blog - Latest News
You are here:
Home
»
Biotechnology Industry News
»
Biotechnology Pitch Competition offers award for best business pitch
August 20, 2012
20
Aug
2012
Biotechnology Pitch Competition offers award for best business pitch
Biotechnology Pitch Competition enhances visibility for nascent biotechnology enterprises, and provides valuable feedback to emerging entrepreneurs.
0
Likes
/
0
Tweets
/
in
Biotechnology Industry News
Get updates by email
Your email:
BiotechBlog’s
Editor
Yali Friedman lives in Washington, DC and is author of
Building Biotechnology
and
other books
; founder of
DrugPatentWatch
; and chief editor of the
Journal of Commercial Biotechnology
.
Read More...
Network
and Share
Categories
Select Category
Biotechnology Book Reviews
Biotechnology Industry News
Biotechnology Videos
Featured
General Biotechnology
Guest content
Talks and Publications
Uncategorized
Featured Content
Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence
Biotechnology and Pharmaceutical Industry Infographics
DNA-o-gram generator — Send a message in the language of life
Popular Posts
Supreme Court Both Invalidates & Upholds Myriad Patents
About
The Developing World’s Agricultural Biotech Potential: An Asian-African Snapshot
Association for Molecular Pathology v Myriad: Attorneys React
Recommended
Reading
Recent
Comments
Making sense of the confusing Supreme Court DNA patent ruling | diveintotech
on
Supreme Court Both Invalidates & Upholds Myriad Patents
Anonymous on
Supreme Court Both Invalidates & Upholds Myriad Patents
BiotechBlog | Introducing DrugChatter -- Analyzing public opinion on popular drugs - BiotechBlog
on
Contact
BiotechBlog | Association for Molecular Pathology v Myriad: Attorneys React - BiotechBlog
on
After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules
Susan K Finston
on
The Answers are in the Crowd? (Part 2) [live from #bio2013]
Translator
←
Genomind Announces New Scientific Advisory Board Member
(previous entry)
(next entry)
Top 50 Opportunities for Generic Pharmaceutical Companies Assessed in…
→
© Copyright -
BiotechBlog
— A
thinkBiotech
product
Send to Email Address
Your Name
Your Email Address
Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.